Why the study?
Does nicardipine improve exercise capacity and reduce ischemic symptoms in patients with stable angina pectoris?
Does nicardipine improve exercise capacity and reduce ischemic symptoms in patients with stable angina pectoris?
Nicardipine improves exercise tolerance and delays the onset of ischemia in patients with stable angina pectoris.
Answers are grounded in this paper and cite their sources.
Improves exercise tolerance and delays ischemia in stable angina; confirms anti-ischemic efficacy of nicardipine in RCT.
Nicardipine, 30 and 40 mg thrice daily, was administered to 66 patients with stable angina pectoris in a multicentre, randomised, double-blind, cross-over trial. With nicardipine therapy, duration of exercise and cumulative oxygen consumption increased, while times to onset of angina and 1 mm ST segment depression were prolonged. Anginal frequency and nitroglycerin consumption declined with use of nicardipine, but this did not reach statistical significance. Resting heart rate increased slightly and resting blood pressure decreased. Two patients on nicardipine and one on placebo sustained acute infarction. Otherwise, side effects were generally mild and transient.
No takes yet. Share an insight, caveat, or question.
Scheidt et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: